Stocks and InvestingStocks and Investing
Mon, May 18, 2020
Fri, May 15, 2020
Thu, May 14, 2020
Wed, May 13, 2020

David Nierengarten Maintained (SWTX) at Buy with Increased Target to $48 on, May 13th, 2020


Published on 2024-10-27 06:21:17 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Buy with Increased Target from $45 to $48 on, May 13th, 2020.

David has made no other calls on SWTX in the last 4 months.



There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $58 on, Tuesday, April 14th, 2020
  • Raghuram Selvaraju of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Increased Target to $60 on, Thursday, March 19th, 2020